Navigation Links
British Journal of Cancer Reports Preclinical Evidence of Positive,Effect of Rice Bran on Intestinal Cancer

Study Shows 51% Reduction in Intestinal Adenomas Suggesting Possible Beneficial Mediation in the Prevention of Intestinal Cancer

EL DORADO HILLS, Calif., March 07, 2007 /PRNewswire/ -- NutraCea announced today the results of a study on the effect of rice bran on the number of intestinal adenomas in cancerous mice, published in the January 9, 2007 online edition of the prestigious British Journal of Cancer conducted at the Department of Cancer Studies and Molecular Medicine, at the University of Leicester, Leicester, UK, has produced some encouraging results on the dietary benefits of rice bran. The results of the controlled study demonstrated that by consuming a suitable daily dose of stabilized rice bran, an average 51% reduction in the number of precancerous adenomas in the stomach and large intestine of mice was observed.

"The results show that the mice that received stabilized rice bran (30%) into their diets had a significant decrease in the number of intestinal adenomas compared to mice on the control diet. Rice bran also decreased intestinal hemorrhage in this group," said Margie Adelman, Senior Vice President of NutraCea. "When rice bran in the mice diet was reduced from 30% to 10%, adenoma development was not significantly retarded compared to those in the control model. This suggests that adenoma-retarding activity of rice bran is dose-related, possibly linked predominately to the fiber content of the bran."

Prof. Andreas Gescher of the University of Leicester in the UK, the principal investigator, says: "We compared the cancer-preventive efficacy of NutraCea Stabilized Rice Bran in mouse models of prostate, breast and intestinal cancers. These mice ate a diet containing 30% rice bran. Whilst there was no effect of rice bran on the development of prostate or breast cancer, rice bran significantly retarded the development of adenomas in so-called "Min mice," a mouse strain which is prone
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
4. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
5. Genetics Journal Thimerosal/Autism Study the Best Science Drug Company Money Can Buy
6. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
7. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
8. Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
9. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
10. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
11. Critical Therapeutics Announces the Publication of Data for ZyfloCR (Zileuton) Extended-Release Tablets in the Journal of Asthma
Post Your Comments:
(Date:8/28/2014)... 2014 The Leukemia & Lymphoma Society ... advance an experimental cancer vaccine to treat patients ... of myeloma. The partnership is through ... forges collaborations with biotechnology companies to help bring ... is developing a vaccine, PVX-410, designed to target ...
(Date:8/28/2014)... -- STAAR Surgical Company (NASDAQ: STAA ) a leading ... for the eye, today announced that management will present at ... Palace Hotel on Wednesday, September 3 at 7:15 a.m. PT/10:15 ... CEO will offer a general overview of the Company,s current ... by Steve Brown , CFO, and Sam Gesten ...
(Date:8/27/2014)... SHENZHEN, China, Aug. 28, 2014 China ... ("Nepstar" or the "Company"), a leading retail drugstore ... directly operated stores, today announced its unaudited financial ... Financial HighlightsFor the quarter ended June 30, ... RMB686.6 million (US$110.7 million) compared to RMB638.8 million in ...
Breaking Medicine Technology:The Leukemia & Lymphoma Society Provides Equity Financing to OncoPep to Support Clinical Trial for Myeloma Vaccine 2STAAR Surgical To Present At The Baird 2014 Health Care Conference 2China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 11
... TAINAN, Taiwan, Nov. 19 ... pharmaceutical ingredients (APIs), announced that its,Tainan facility has ... Inc. The Certification confirms ScinoPharm,s,competency and proficiency in ... and applies to specific laboratories and,production areas used ...
... , , DAYTON, Ohio, Nov. 19 Riverain ... with leading Canadian medical imaging distributor Christie Group to ... CAD. The exclusive agreement will bring Dayton, Ohio based ... Group,s established and reputable sales channel. , SoftView Enhanced ...
Cached Medicine Technology:ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2
(Date:8/28/2014)... Clarity PSO , an operating ... a federal Patient Safety Organization (PSO) for another three-year ... Research and Quality (AHRQ). Clarity PSO will continue to ... following the true intentions of the Patient Safety and ... proud and eager to continue our journey as a ...
(Date:8/28/2014)... Salt Lake City, UT (PRWEB) August 28, 2014 ... more attention to coordination and integration of care to address ... to improve the quality of care outcomes (with more provider ... are anticipated where all the people involved in the care ... and have to figure out how to distribute it. If ...
(Date:8/28/2014)... On September 10, the Mesothelioma Applied Research ... president and CEO of Aduro BioTech, during a new ... live broadcast. The interview will be led by ... nurse practitioner, Mary Hesdorffer, APRN . , The ... therapy for malignant pleural mesothelioma, known as CRS-207. CRS-207 ...
(Date:8/28/2014)... 28, 2014 Hastings and Hastings, a ... of experience in the industry is pleased to report ... that totaled approximately $125,000. This is exciting news for ... clear and well defined proof that Hastings and Hastings ... discount attorney's fees. Saving clients money when it comes ...
(Date:8/28/2014)... Vitals, a recognized and trusted website for finding and ... Dermatology one of their Top 10 Doctors for 2014 ... their doctor experiences and rate their doctors on a number ... Vitals Top 10 Doctor recognition means that out of all ... the highest by patients. , “I’m honored to receive this ...
Breaking Medicine News(10 mins):Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3Health News:Med-Certification.com Expects Industry "Hiccups" with New Models for Patient Care and Reimbursement 2Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 2Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $13,750 On A Settlement Of $125,000 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $13,750 On A Settlement Of $125,000 3Health News:Dr. Sabrina Fabi of Cosmetic Laser Dermatology Recognized as Vitals Top 10 Doctor 2
... heart risk may not be accurate in some cases ... from the United States and the Netherlands, question the ... in predicting heart disease and cardiovascular death. , The ... in that Massachusetts community, allows doctors to assess risk ...
... Alliance of relief organizations offers five action steps to ... cease fires to allow the delivery of food and ... of 750,000 people still lack access to food, clean ... working in the region see this arrangement to allow ...
... Senator Dole introduces Senator Daschle at his confirmation hearing ... Services , WASHINGTON, Jan. 8 Bipartisan Policy Center ... Department of Health and Human Services Secretary, was introduced ... at his confirmation hearing today. The hearing was convened ...
... bad cholesterol more effectively than Zocor , , THURSDAY, Jan. ... review, U.S. health officials said Thursday that they supported ... , The U.S. Food and Drug Administration said there ... patients taking Vytorin and patients taking the drug Zocor. ...
... Healthcare,Solutions, Inc., formerly Allscripts Healthcare Solutions, Inc. (Allscripts ... the three and six,months ended November 30, 2008. ... ) , The Company,s ... November 30, 2008,include results from legacy Allscripts for ...
... Jan. 8 The Pew Charitable Trusts announced today ... and food safety programs, in its Health & Human ... director and general counsel of the Senate Committee on ... experience in environmental policy and consumer advocacy to Pew. ...
Cached Medicine News:Health News:Studies Challenge Framingham Risk Score 2Health News:Studies Challenge Framingham Risk Score 3Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 2Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 3Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 3Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 4Health News:FDA Backs Cholesterol Drug Vytorin 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2
The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
The Medtronic Model 6495 bipolar coaxial temporary pacing lead is designed to provide the advantages of bipolar technology based on the sensing and pacing capabilities of the Medtronic Model 6500 uni...
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
Medicine Products: